Verrica Gets CRL From FDA For VP-102 NDA For The Treatment Of Molluscum Contagiosum
UniQure Says FDA Accepts BLA For Etranacogene Dezaparvovec Under Priority Review
Merck: European Commission Approves KEYTRUDA Plus Chemotherapy In Breast Cancer
Roivant Sciences: FDA Approves Dermavant's VTAMA Cream, 1% For Plaque Psoriasis In Adults
SpringWorks Therapeutics Says Nirogacestat Meets Endpoints In Phase 3 DeFi Trial
Hikma Pharma: Siggi Olafsson Resigns As CEO
Innoviva To Acquire Entasis Therapeutics For $2.20/Shr Cash
Ocugen Says FDA Lifts Clinical Hold On Company's Phase 2/3 Clinical Trial, OCU-002, For COVAXIN
Merck KGaA To Invest EUR 440 Mln In Two Major Life Science Projects In Ireland Over Five Years
AstraZeneca's Covid-19 Vaccine Vaxzevria Gets EU Approval As Third Dose Booster